alexa Studying Of Lipid Metabolism In Experimental Diabetes And Ways Of Its Correction
ISSN: 2153-0769

Metabolomics:Open Access
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

8th International Conference and Exhibition on Metabolomics & Systems Biology
May 08-10, 2017 Singapore

Tursunov Djakhangir
Tashkent Medical Academy, Uzbekistan
Posters & Accepted Abstracts: Metabolomics
DOI: 10.4172/2153-0769-C1-038
Abstract
Objective: The aim of the research is to study the disorders of lipid metabolism in experimental diabetes and its correction with ecdysten. Materials & Methods: Research was conducted on white rats, weighing 120-140 g. Model alloxan diabetes was induced by administration of alloxan 15 mg per 100 g of body weight. At 7, 14, 21 days experiment investigated the glucose in the blood. On the 7th day of the experiment, we began administering ecdysten and the rats were treated with this for 14 days. As a comparison, we took glucophage and retabolil drugs. Results: Main characteristic of dyslipidemia in diabetes is, increasing level of triglycerides in the composition of VLDL and decreased HDL cholesterol. Low-density lipoprotein cholesterol concentrations in diabetic patients does not differ from that of people without the disease, but in patients with type 2 diabetes predominant fraction of small, dense LDL with increased atherogenesis due to the high oxidizing ability. Quantitative changes in lipid profile may occur in isolation, but more often they are combined and are called lipid triad or atherogenic dyslipidemia. Conclusion: Thus, treatment of experimental animals with ecdysten and glyukofage within 14-21 days, more significantly reduced triglycerides compared to the control. If the 7th day of treatment, triglyceride levels had a tendency to exceed the values of intact rats. By the 14th day, this figure did not differ from the normative values. Treatment with ratabolil slightly reduces the concentration of triglycerides as compared to control. The concentration of HDL cholesterol in the 14-21 days of treatment with retabolil was dramatically reduced as compared with the control animals and intact groups, but treatment ecdysten and glucophage, especially ecdysten, increased HDL-C concentration is almost 2-fold compared with the control. Regarding triglyceride levels, the treatment ecdysten glyukofage and experimental animals with alloxan diabetes within 14-21 days and significantly reduces their contents and retabolil increases.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords